| Title |
Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro
|
|---|---|
| Published in |
Psychopharmacology, February 2014
|
| DOI | 10.1007/s00213-014-3446-0 |
| Pubmed ID | |
| Authors |
Aaron Janowsky, Amy J. Eshleman, Robert A. Johnson, Katherine M. Wolfrum, David J. Hinrichs, Jongtae Yang, T. Mark Zabriskie, Martin J. Smilkstein, Michael K. Riscoe |
| Abstract |
Mefloquine is used for the prevention and treatment of chloroquine-resistant malaria, but its use is associated with nightmares, hallucinations, and exacerbation of symptoms of post-traumatic stress disorder. We hypothesized that potential mechanisms of action for the adverse psychotropic effects of mefloquine resemble those of other known psychotomimetics. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 25% |
| United States | 1 | 25% |
| United Kingdom | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 50% |
| Science communicators (journalists, bloggers, editors) | 1 | 25% |
| Members of the public | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 3% |
| United Kingdom | 1 | 1% |
| Unknown | 70 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 14% |
| Student > Master | 10 | 14% |
| Student > Bachelor | 6 | 8% |
| Student > Ph. D. Student | 6 | 8% |
| Student > Postgraduate | 6 | 8% |
| Other | 16 | 22% |
| Unknown | 19 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 10 | 14% |
| Neuroscience | 9 | 12% |
| Medicine and Dentistry | 8 | 11% |
| Biochemistry, Genetics and Molecular Biology | 7 | 10% |
| Agricultural and Biological Sciences | 7 | 10% |
| Other | 14 | 19% |
| Unknown | 18 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2024.
All research outputs
#4,694,098
of 25,069,047 outputs
Outputs from Psychopharmacology
#1,177
of 5,596 outputs
Outputs of similar age
#52,731
of 320,394 outputs
Outputs of similar age from Psychopharmacology
#16
of 73 outputs
Altmetric has tracked 25,069,047 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,596 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,394 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.